60 related articles for article (PubMed ID: 8293008)
1. [Is it possible to identify women with rapid vertebral bone loss during menopause? Result of a longitudinal study of 92 women at the onset of menopause].
Pouillès JM; Trémollières F; Ribot C
Rev Rhum Ed Fr; 1993 Mar; 60(3):217-22. PubMed ID: 8293008
[TBL] [Abstract][Full Text] [Related]
2. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
3. Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.
Löfman O; Magnusson P; Toss G; Larsson L
Clin Chim Acta; 2005 Jun; 356(1-2):67-75. PubMed ID: 15936304
[TBL] [Abstract][Full Text] [Related]
4. [Postmenopausal bone loss: results of a topographic study by X-ray absorptiometry].
Pouillès JM; Tremollières F; Saint-Martin F; Ribot C
Rev Rhum Ed Fr; 1993 Dec; 60(12):891-6. PubMed ID: 8012314
[TBL] [Abstract][Full Text] [Related]
5. [Preliminary study on bone loss rate in early and late stages of post-menopausal women].
Xu H; Wu Y; Yan Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Sep; 33(9):542-5. PubMed ID: 10806731
[TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Fahrleitner A; Prenner G; Kniepeiss D; Iberer F; Tscheliessnigg KH; Piswanger-Sölkner C; Obermayer-Pietsch B; Leb G; Dobnig H
Wien Klin Wochenschr; 2002 Aug; 114(15-16):717-24. PubMed ID: 12602117
[TBL] [Abstract][Full Text] [Related]
7. The effect of calcitonin on biochemical markers and zinc excretion in postmenopausal osteoporosis.
Colpan L; Gur A; Cevik R; Nas K; Sarac AJ
Maturitas; 2005 Jul; 51(3):246-53. PubMed ID: 15978968
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors of vertebral osteoporosis. Results of a study of 2279 women referred to a menopause clinic].
Pouilles JM; Ribot C; Trémollières F; Bonneu M; Brun S
Rev Rhum Mal Osteoartic; 1991 Mar; 58(3):169-77. PubMed ID: 2057689
[TBL] [Abstract][Full Text] [Related]
9. [Analytic study of the reliability of an integrated mineralometric and biochemical system in the dynamic evaluation of the bone mineral content after menopause].
Carone D; Miglionico F; Vizziello G; Fanizza G
Minerva Ginecol; 1994 Apr; 46(4):161-5. PubMed ID: 8065588
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the effectiveness of 17-beta-estradiol and calcitonin in women with postmenopausal bone loss].
Stĕpán J; Formánková J; Masatová A; Michalský M; Rosenová Z
Cas Lek Cesk; 1997 Apr; 136(8):242-8. PubMed ID: 9264868
[TBL] [Abstract][Full Text] [Related]
12. L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.
La Vignera S; Vicari E; Tumino S; Ciotta L; Condorelli R; Vicari LO; Calogero AE
Minerva Ginecol; 2008 Dec; 60(6):475-84. PubMed ID: 18981975
[TBL] [Abstract][Full Text] [Related]
13. Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory.
Nabipour I; Larijani B; Vahdat K; Assadi M; Jafari SM; Ahmadi E; Movahed A; Moradhaseli F; Sanjdideh Z; Obeidi N; Amiri Z
Menopause; 2009; 16(5):950-5. PubMed ID: 19387415
[TBL] [Abstract][Full Text] [Related]
14. Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
Gennari C; Agnusdei D; Crepaldi G; Isaia G; Mazzuoli G; Ortolani S; Bufalino L; Passeri M
Menopause; 1998; 5(1):9-15. PubMed ID: 9689189
[TBL] [Abstract][Full Text] [Related]
15. [Biochemical markers of bone turnover : clinical usefulness in osteoporosis].
Garnero P; Delmas PD
Ann Biol Clin (Paris); 1999; 57(2):137-48. PubMed ID: 10210740
[TBL] [Abstract][Full Text] [Related]
16. [Observations on bone mineral metabolism in natural and surgical menopause. Role of synthetic salmon calcitonin and calcium on bone turnover].
Ferrante B; Isa L; Uderzo A
Minerva Ginecol; 1993 Mar; 45(3):87-93. PubMed ID: 8332282
[TBL] [Abstract][Full Text] [Related]
17. Determinants of bone mass in postmenopausal women.
Aloia JF; Vaswani AN; Yeh JK; Ross P; Ellis K; Cohn SH
Arch Intern Med; 1983 Sep; 143(9):1700-4. PubMed ID: 6615091
[TBL] [Abstract][Full Text] [Related]
18. [Relation between laboratory tests and densitometry values: characterization of the baseline profile in a perimenopausal population at anamnestic risk for osteoporosis].
Tassan Simonat P; Bianco V; Colombo A
Ann Ostet Ginecol Med Perinat; 1991; 112(2):108-20. PubMed ID: 1776776
[TBL] [Abstract][Full Text] [Related]
19. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women.
Tremollieres FA; Pouilles JM; Ribot C
J Clin Endocrinol Metab; 1993 Sep; 77(3):683-6. PubMed ID: 8370689
[TBL] [Abstract][Full Text] [Related]
20. [Vertebral bone loss in perimenopause. Results of a 7-year longitudinal study].
Pouillès JM; Trémollières F; Ribot C
Presse Med; 1996 Feb; 25(7):277-80. PubMed ID: 8685165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
